HCW Biologics(HCWB)
MIRAMAR, FLBiotechnology
Focus: HCW Biologics is a publicly traded immunotherapy biotech focused on oncology and dermatology, headquartered in Miramar, FL and founded in 2021. The company is in early-stage clinical development with minimal revenue and substantial R&D investment.
Profile data last refreshed 5h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About HCW Biologics
AI assessmentNot HiringNo open roles listed right now. Follow HCW Biologics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from HCW Biologics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$3M
FY2025
Pipeline & Clinical Trials
HCW9302, an IL-2 fusion protein
Alopecia Areata(AA)Clinical Trials (1)
NCT07049328HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Phase 1Help build intelligence for HCW Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.